BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3485013)

  • 21. Morphological changes in leukemic lymphoblasts and normal lymphocytes treated with deoxyadenosine plus deoxycoformycin.
    Matsumoto SS; Yu AL; Yu J
    Cancer Invest; 1985; 3(3):225-33. PubMed ID: 3873981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dipyridamole enhancement of toxicity to L1210 cells by deoxyadenosine and deoxycoformycin combinations in vitro.
    Kang GJ; Kimball AP
    Cancer Res; 1984 Feb; 44(2):461-6. PubMed ID: 6362851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
    Goday A; Simmonds HA; Morris GS; Fairbanks LD
    Biochem Pharmacol; 1985 Oct; 34(19):3561-9. PubMed ID: 3876835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 2'-deoxycoformycin on the metabolism of purines and the survival of malignant cells in a patient with T-cell leukemia.
    Yu AL; Bakay B; Kung FH; Nyhan WL
    Cancer Res; 1981 Jul; 41(7):2677-82. PubMed ID: 6972800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of 3H-thymidine incorporation by adenosine and deoxyadenosine in human peripheral lymphocytes and malignant lymphoid cell lines.
    van der Krann PM; van Zandvoort PM; De Abreu RA; Bakkeren JA; van Laarhoven JP; de Bruijn CH
    Adv Exp Med Biol; 1986; 195 Pt B():213-9. PubMed ID: 3490120
    [No Abstract]   [Full Text] [Related]  

  • 26. Mechanism of adenosine triphosphate catabolism induced by deoxyadenosine and by nucleoside analogues in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Cancer Res; 1989 Sep; 49(18):4983-9. PubMed ID: 2788493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitor of 2', 5'-oligoadenylate synthetase induced in human T lymphoblastoid cell line treated with deoxyadenosine, deoxycoformycin and interferon.
    Heike T; Katamura K; Kubota M; Shinomiya K; Mikawa H
    Adv Exp Med Biol; 1986; 195 Pt B():683-7. PubMed ID: 3490130
    [No Abstract]   [Full Text] [Related]  

  • 28. Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
    Kefford RF; Fox RM
    Cancer Res; 1982 Jan; 42(1):324-30. PubMed ID: 6976204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of deoxyadenosine on the activation of ADA inhibited T & B cells.
    Webster AD; Ip H; Pereira S
    Clin Exp Immunol; 1982 Dec; 50(3):587-95. PubMed ID: 6299634
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of 9-beta-D-arabinofuranosyladenine 5'-triphosphate and deoxyadenosine triphosphate in leukemic cells by 2'-deoxycoformycin during therapy with 9-beta-D-arabinofuranosyladenine.
    Plunkett W; Benjamin RS; Keating MJ; Freireich EJ
    Cancer Res; 1982 May; 42(5):2092-6. PubMed ID: 6175407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
    Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
    Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicity and immunosuppressive activity of binary combinations of 2'-deoxycoformycin and 2'-deoxyadenosine.
    Paine RM; Weston BJ; Clink HM; Kohn J; Neville AM; McGhee KG; Harrap KR
    Cancer Treat Rep; 1981; 65(3-4):259-66. PubMed ID: 6972254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purine metabolizing enzymes of lymphocyte cell populations: correlation between AMP-deaminase activity and dATP accumulation in murine lymphocytes.
    Dornand J; Clofent G; Bonnafous JC; Favero J; Mani JC
    Proc Soc Exp Biol Med; 1985 Sep; 179(4):448-55. PubMed ID: 2991938
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of nucleosides and deoxycoformycin on adenosine and deoxyadenosine inhibition of human lymphocyte activation.
    Uberti J; Lightbody JJ; Johnson RM
    J Immunol; 1979 Jul; 123(1):189-93. PubMed ID: 312874
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical mechanisms of deoxycoformycin toxicity in chronic leukemias.
    Ganeshaguru K; Ho AD; Piga A; Catovsky D; Hoffbrand AV
    Leuk Res; 1987; 11(10):941-5. PubMed ID: 3500370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deoxy-ATP accumulation in adenosine deaminase-inhibited human B and T lymphocytes.
    Gruber HE; Cohen AH; Firestein GS; Redelman D; Bluestein HG
    Adv Exp Med Biol; 1986; 195 Pt A():503-7. PubMed ID: 3487921
    [No Abstract]   [Full Text] [Related]  

  • 37. Adenosine and deoxyadenosine toxicity in colony assay systems for human T-lymphocytes, B-lymphocytes, and granulocytes.
    Brox LW; Pollock E; Belch A
    Cancer Chemother Pharmacol; 1982; 9(1):49-52. PubMed ID: 6982786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of adenosine deaminase deficiency.
    Albert D; Bluestein HG; Thompson L; Seegmiller JE
    Cell Immunol; 1984 Jul; 86(2):510-7. PubMed ID: 6610485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S-adenosylhomocysteine hydrolase activity, deoxyadenosine triphosphate accumulation, and competence of thymocyte and spleen leucocyte response to mitogens in coformycin-treated mice.
    Lukey T; Snyder FF
    Biochem Pharmacol; 1983 Apr; 32(8):1399-406. PubMed ID: 6860359
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased NAD+ content in human T lymphoblastoid cells treated simultaneously with 2'-deoxycoformycin and 2'-deoxyadenosine.
    Koya M; Kanoh T; Uchino H; Ueda K
    Nihon Ketsueki Gakkai Zasshi; 1985 Jul; 48(4):1003-11. PubMed ID: 3877388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.